Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Curr Opin Immunol. 2021 Jun 23;72:196–205. doi: 10.1016/j.coi.2021.06.006

Figure 2.

Figure 2.

Mechanisms of Type I Interferon signaling dysregulation in Down syndrome. Diagram of JAK-STAT signaling upon IFN-I binding followed by induction of IFN-stimulated genes (ISGs). Downstream effects of ISGs including viral protection and negative regulation of the IFN-Ireceptor are outlined. Blue boxes denote alterations characterized in Down syndrome.